Porter LL - Search Results

1

Oral dolasetron mesylate in patients receiving moderately emetogenic platinum-containing chemotherapy. Oral Dolasetron Dose Response Study Group.

Grote TH, Pineda LF, Figlin RA, Pendergrass KB, Hesketh PJ, Karlan BY, Reeves JA, Porter LL, Benedict CR, Hahne WF. Grote TH, et al. Among authors: porter ll. Cancer J Sci Am. 1997 Jan-Feb;3(1):45-51. Cancer J Sci Am. 1997. PMID: 9072308 Clinical Trial.

2

Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ. Hortobagyi GN, et al. J Clin Oncol. 1998 Jun;16(6):2038-44. doi: 10.1200/JCO.1998.16.6.2038. J Clin Oncol. 1998. PMID: 9626201 Clinical Trial.

3

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.

Berenson JR, Rosen LS, Howell A, Porter L, Coleman RE, Morley W, Dreicer R, Kuross SA, Lipton A, Seaman JJ. Berenson JR, et al. Cancer. 2001 Apr 1;91(7):1191-200. doi: 10.1002/1097-0142(20010401)91:7<1191::aid-cncr1119>3.0.co;2-0. Cancer. 2001. PMID: 11283917 Clinical Trial.

4

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group.

Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Simeone JF, Seaman J, Knight RD. Hortobagyi GN, et al. N Engl J Med. 1996 Dec 12;335(24):1785-91. doi: 10.1056/NEJM199612123352401. N Engl J Med. 1996. PMID: 8965890 Free article. Clinical Trial.

5

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.

Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD. Berenson JR, et al. N Engl J Med. 1996 Feb 22;334(8):488-93. doi: 10.1056/NEJM199602223340802. N Engl J Med. 1996. PMID: 8559201 Free article. Clinical Trial.

6

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.

Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone JF, Reitsma DJ, Heffernan M, Seaman J, Knight RD. Berenson JR, et al. J Clin Oncol. 1998 Feb;16(2):593-602. doi: 10.1200/JCO.1998.16.2.593. J Clin Oncol. 1998. PMID: 9469347 Clinical Trial.

7

Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.

Buzdar A, Douma J, Davidson N, Elledge R, Morgan M, Smith R, Porter L, Nabholtz J, Xiang X, Brady C. Buzdar A, et al. J Clin Oncol. 2001 Jul 15;19(14):3357-66. doi: 10.1200/JCO.2001.19.14.3357. J Clin Oncol. 2001. PMID: 11454883 Clinical Trial.

8

Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.

Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD; CHAMP Investigators. Powers SW, et al. Among authors: porter ll. N Engl J Med. 2017 Jan 12;376(2):115-124. doi: 10.1056/NEJMoa1610384. Epub 2016 Oct 27. N Engl J Med. 2017. PMID: 27788026 Free PMC article. Clinical Trial.

9

Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer.

Sarosdy MF, Schellhammer PF, Soloway MS, Vogelzang NJ, Crawford ED, Presti J, Chodak GW, Mitchell P, Porter L. Sarosdy MF, et al. BJU Int. 1999 May;83(7):801-6. doi: 10.1046/j.1464-410x.1999.00028.x. BJU Int. 1999. PMID: 10368200 Clinical Trial.

10

Characteristics of GABAergic neurons and their synaptic relationships with intrinsic axons in the cat motor cortex.

Porter LL, Matin D, Keller A. Porter LL, et al. Somatosens Mot Res. 2000;17(1):67-80. doi: 10.1080/08990220070319. Somatosens Mot Res. 2000. PMID: 10833086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters